As of 2024-09-14, the Fair Value of bluebird bio Inc (BLUE) is -2.40 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.61 USD, the upside of bluebird bio Inc is -495.42%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 5Y Avg | |
| Net income | -555.63 | -789.61 | -618.70 | -819.38 | -266.58 | -609.98 |
| YoY growth | -65.54% | -42.11% | 21.64% | -32.44% | 67.47% | -10.20% |
| Market Cap (mil) | 115.32 |
| P/E | |
| Forward P/E |
| EPS | -0.48 |
| Avg earnings growth rate | -10.20% |
| TTM earnings | -91.20 |